# Myra Vision

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/myra-vision

- Industry: Medical Devices & Equipment
- Headquarters: Campbell, US
- Website: www.myravision.com
- Total disclosed funding: $28M
- Latest round: Series B (Jun 23, 2023)
- Investors on record: 3

## About

Based in California, US, Myra Vision Inc., formerly known as Myra Medical, Inc. operates as a medical technology company that develops glaucoma devices. The company was founded by Robert Chang, and in June 2023, Myra Vision, Inc. raised USD 25 million in series B funding from The Capital Partnership (U.K.) Limited and Cormorant Asset Management, with participation from PA MedTech VC Fund.

Myra Vision provides a nanotechnology device that enables doctors or surgeons to safely maximize intraocular pressure (IOP) reduction for patients with moderate to severe glaucoma.

The company plans to use the June 2023 funding to expand its product development and clinical procedure.

## Funding rounds

- Series B, Jun 23, 2023, $12M — Cormorant Asset Management, The Capital Partnership (U.K.) Limited, PA MedTech VC Fund
- Series A, Jun 1, 2021, $15M — Cormorant Asset Management, The Capital Partnership (U.K.) Limited

## Investors

- Cormorant Asset Management (https://capitalatlas.ai/funds/cormorant-asset-management) — Series A, Series B
- The Capital Partnership (U.K.) Limited — Series A, Series B
- PA MedTech VC Fund — Series B